American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (986)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1255)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (62)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5172)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Two decade single institution experience highlights rare survivors with relapsed or refractory Burkitt lymphoma
    Meeting Abstract

    Molla, R.; Berman, E.; Caron, P.; Donnelly, G.; Falchi, L.; Hamlin, P. A.; Horwitz, S.; Intlekofer, A. M.; Johnson, W. T.; Jurcic, J. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Rituximab plus /- ibrutinib as first line therapy for marginal zone lymphoma
    Meeting Abstract

    Noy, A.; Thet, W. S.; Vemuri, S.; Seshan, V.; Batlevi, C. L.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Habermann, T. M.; Hamlin, P. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Association between sleep traits and risk of non-Hodgkin's lymphoma subtypes: A mendelian randomization study in the International Lymphoma (InterLymph) Epidemiology Consortium
    Meeting Abstract

    Shah, P.; Crawford, B.; Merchant, A.; Birmann, B. M.; Macauda, A.; Hildebrandt, M. A. T.; Norman, A. D.; Caporaso, N.; Yeager, M.; Dean, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A phase 1/1b open-label, dose escalation, first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-leukemic activity of the orally available CDC-like Kinase inhibitor, BH-30236, in adults with R/R AML or HR-MDS
    Meeting Abstract

    Stein, E. M.; Boussi, L.; Mims, A.; Watts, J. M.; Mannis, G. N.; Liu, H.; Sallman, D.; Ravandi, F.; Schiller, G. J.; Wang, E. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) for chimeric antigen receptor T-cell therapy (CAR-T) and T-cell engager antibody (TCE) in myeloma and lymphoma
    Meeting Abstract

    Ayoobkhan, F. S.; Qureshi, R.; Rahman, R. L.; Faiz, Z.; Irfan, S.; Iftikhar, A.; Ansari, B.; Mushtaq, M. U.; Abdallah, A. O.; Raza, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Meeting Abstract

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G.; Borge, P.; Geyer, M. B.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A phase II study of the menin inhibitor revumenib in leukemia associated with upregulation of HOX genes: Trial in progress
    Meeting Abstract

    Issa, G. C.; Chin, K. K.; Blachly, J. S.; Farhat, A.; Xiao, L.; Ning, J.; Cuglievan, B.; Shukla, N.; Sasaki, K.; Loghavi, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • AL amyloidosis: Understanding the clinical prodrome and delays in diagnosis
    Meeting Abstract

    Abdallah, N.; Hydren, J. R.; Barnes, M. S.; Wood, A.; Tuchman, S. A.; Zonder, J. A.; Bianchi, G.; Landau, H. J.; Baljevic, M.; Hoffman, J. E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Long-term follow-up of real-world teclistamab therapy for relapsed/refractory multiple myeloma from the IMWG Immunotherapy Working Group Committee
    Meeting Abstract

    Tan, C. R.; Asoori, S.; Nemirovsky, D.; Derkach, A.; Brunaldi, L.; Popat, R.; Lau, C.; Kastritis, E.; Martínez-Lopez, J.; Bansal, R.; more...
    Blood (2024)

    Fulltext@MSK | Save